IBDEI01B ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1265,1,2,0)
 ;;=2^ESRD
 ;;^UTILITY(U,$J,358.3,1265,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,1266,0)
 ;;=V58.69^^12^102^14
 ;;^UTILITY(U,$J,358.3,1266,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1266,1,1,0)
 ;;=1^V58.69
 ;;^UTILITY(U,$J,358.3,1266,1,2,0)
 ;;=2^L/T CURRENT USE OF OTHER MEDS
 ;;^UTILITY(U,$J,358.3,1266,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,1267,0)
 ;;=V58.61^^12^103^14
 ;;^UTILITY(U,$J,358.3,1267,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1267,1,1,0)
 ;;=1^V58.61
 ;;^UTILITY(U,$J,358.3,1267,1,2,0)
 ;;=2^L/T (CURRENT) USE - ANTICOAG
 ;;^UTILITY(U,$J,358.3,1267,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,1268,0)
 ;;=427.31^^12^103^1
 ;;^UTILITY(U,$J,358.3,1268,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1268,1,1,0)
 ;;=1^427.31
 ;;^UTILITY(U,$J,358.3,1268,1,2,0)
 ;;=2^ATRIAL FIBRILLATION
 ;;^UTILITY(U,$J,358.3,1268,2)
 ;;=^11378
 ;;^UTILITY(U,$J,358.3,1269,0)
 ;;=427.32^^12^103^2
 ;;^UTILITY(U,$J,358.3,1269,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1269,1,1,0)
 ;;=1^427.32
 ;;^UTILITY(U,$J,358.3,1269,1,2,0)
 ;;=2^ATRIAL FLUTTER
 ;;^UTILITY(U,$J,358.3,1269,2)
 ;;=^11387
 ;;^UTILITY(U,$J,358.3,1270,0)
 ;;=414.00^^12^103^3
 ;;^UTILITY(U,$J,358.3,1270,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1270,1,1,0)
 ;;=1^414.00
 ;;^UTILITY(U,$J,358.3,1270,1,2,0)
 ;;=2^CAD
 ;;^UTILITY(U,$J,358.3,1270,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,1271,0)
 ;;=425.4^^12^103^4
 ;;^UTILITY(U,$J,358.3,1271,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1271,1,1,0)
 ;;=1^425.4
 ;;^UTILITY(U,$J,358.3,1271,1,2,0)
 ;;=2^CARDIOMYOPATHY
 ;;^UTILITY(U,$J,358.3,1271,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,1272,0)
 ;;=V65.49^^12^103^5
 ;;^UTILITY(U,$J,358.3,1272,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1272,1,1,0)
 ;;=1^V65.49
 ;;^UTILITY(U,$J,358.3,1272,1,2,0)
 ;;=2^COUNSELING
 ;;^UTILITY(U,$J,358.3,1272,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,1273,0)
 ;;=V43.3^^12^103^6
 ;;^UTILITY(U,$J,358.3,1273,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1273,1,1,0)
 ;;=1^V43.3
 ;;^UTILITY(U,$J,358.3,1273,1,2,0)
 ;;=2^HEART VALVE REPLACEMENT
 ;;^UTILITY(U,$J,358.3,1273,2)
 ;;=^295440
 ;;^UTILITY(U,$J,358.3,1274,0)
 ;;=V67.51^^12^103^7
 ;;^UTILITY(U,$J,358.3,1274,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1274,1,1,0)
 ;;=1^V67.51
 ;;^UTILITY(U,$J,358.3,1274,1,2,0)
 ;;=2^HI-RISK RX F-U EXAM, NEC
 ;;^UTILITY(U,$J,358.3,1274,2)
 ;;=^295577
 ;;^UTILITY(U,$J,358.3,1275,0)
 ;;=V12.59^^12^103^8
 ;;^UTILITY(U,$J,358.3,1275,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1275,1,1,0)
 ;;=1^V12.59
 ;;^UTILITY(U,$J,358.3,1275,1,2,0)
 ;;=2^HX OF CIRCULATORY DISEASE
 ;;^UTILITY(U,$J,358.3,1275,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,1276,0)
 ;;=V12.51^^12^103^9
 ;;^UTILITY(U,$J,358.3,1276,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1276,1,1,0)
 ;;=1^V12.51
 ;;^UTILITY(U,$J,358.3,1276,1,2,0)
 ;;=2^HX OF THROMBOSIS/EMBOLISM
 ;;^UTILITY(U,$J,358.3,1276,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,1277,0)
 ;;=272.4^^12^103^11
 ;;^UTILITY(U,$J,358.3,1277,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1277,1,1,0)
 ;;=1^272.4
 ;;^UTILITY(U,$J,358.3,1277,1,2,0)
 ;;=2^HYPERLIPIDEMIA NOS
 ;;^UTILITY(U,$J,358.3,1277,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,1278,0)
 ;;=401.9^^12^103^12
 ;;^UTILITY(U,$J,358.3,1278,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1278,1,1,0)
 ;;=1^401.9
 ;;^UTILITY(U,$J,358.3,1278,1,2,0)
 ;;=2^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,1278,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,1279,0)
 ;;=V68.1^^12^103^13
 ;;^UTILITY(U,$J,358.3,1279,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1279,1,1,0)
 ;;=1^V68.1
 ;;^UTILITY(U,$J,358.3,1279,1,2,0)
 ;;=2^ISSUE REPEAT RX
 ;;^UTILITY(U,$J,358.3,1279,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,1280,0)
 ;;=V12.55^^12^103^10
 ;;^UTILITY(U,$J,358.3,1280,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1280,1,1,0)
 ;;=1^V12.55
 ;;^UTILITY(U,$J,358.3,1280,1,2,0)
 ;;=2^HX OF PULMONARY EMBOLISM
 ;;^UTILITY(U,$J,358.3,1280,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,1281,0)
 ;;=V58.83^^13^104^1
 ;;^UTILITY(U,$J,358.3,1281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1281,1,3,0)
 ;;=3^THERAPEUTIC DRUG MONITORING
 ;;^UTILITY(U,$J,358.3,1281,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,1281,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,1282,0)
 ;;=99605^^14^105^1^^^^1
 ;;^UTILITY(U,$J,358.3,1282,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1282,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,1282,1,3,0)
 ;;=3^99605
 ;;^UTILITY(U,$J,358.3,1283,0)
 ;;=99607^^14^105^2^^^^1
 ;;^UTILITY(U,$J,358.3,1283,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1283,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,1283,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,1284,0)
 ;;=99606^^14^106^1^^^^1
 ;;^UTILITY(U,$J,358.3,1284,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1284,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,1284,1,3,0)
 ;;=3^99606
 ;;^UTILITY(U,$J,358.3,1285,0)
 ;;=99607^^14^106^2^^^^1
 ;;^UTILITY(U,$J,358.3,1285,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1285,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,1285,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,1286,0)
 ;;=98960^^14^107^1^^^^1
 ;;^UTILITY(U,$J,358.3,1286,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1286,1,2,0)
 ;;=2^INDIVIDUAL PATIENT, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,1286,1,3,0)
 ;;=3^98960
 ;;^UTILITY(U,$J,358.3,1287,0)
 ;;=98961^^14^107^2^^^^1
 ;;^UTILITY(U,$J,358.3,1287,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1287,1,2,0)
 ;;=2^2-4 PATIENTS, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,1287,1,3,0)
 ;;=3^98961
 ;;^UTILITY(U,$J,358.3,1288,0)
 ;;=98962^^14^107^3^^^^1
 ;;^UTILITY(U,$J,358.3,1288,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1288,1,2,0)
 ;;=2^5-8 PATIENTS, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,1288,1,3,0)
 ;;=3^98962
 ;;^UTILITY(U,$J,358.3,1289,0)
 ;;=V72.0^^15^108^2
 ;;^UTILITY(U,$J,358.3,1289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1289,1,3,0)
 ;;=3^EYE VISION EXAMINATION
 ;;^UTILITY(U,$J,358.3,1289,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,1289,2)
 ;;=^43432
 ;;^UTILITY(U,$J,358.3,1290,0)
 ;;=V72.11^^15^108^3
 ;;^UTILITY(U,$J,358.3,1290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1290,1,3,0)
 ;;=3^HEARING EXAM-FAIL SCREEN
 ;;^UTILITY(U,$J,358.3,1290,1,4,0)
 ;;=4^V72.11
 ;;^UTILITY(U,$J,358.3,1290,2)
 ;;=^334218
 ;;^UTILITY(U,$J,358.3,1291,0)
 ;;=V72.19^^15^108^1
 ;;^UTILITY(U,$J,358.3,1291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1291,1,3,0)
 ;;=3^EARS & HEARING EXAM NEC
 ;;^UTILITY(U,$J,358.3,1291,1,4,0)
 ;;=4^V72.19
 ;;^UTILITY(U,$J,358.3,1291,2)
 ;;=^334219
 ;;^UTILITY(U,$J,358.3,1292,0)
 ;;=V72.7^^15^108^81
 ;;^UTILITY(U,$J,358.3,1292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1292,1,3,0)
 ;;=3^SKIN/SENSITIZATION TESTS
 ;;^UTILITY(U,$J,358.3,1292,1,4,0)
 ;;=4^V72.7
 ;;^UTILITY(U,$J,358.3,1292,2)
 ;;=^295616
 ;;^UTILITY(U,$J,358.3,1293,0)
 ;;=V73.5^^15^108^5
 ;;^UTILITY(U,$J,358.3,1293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1293,1,3,0)
 ;;=3^SCREEN-ARBOVIRUS DIS
 ;;^UTILITY(U,$J,358.3,1293,1,4,0)
 ;;=4^V73.5
 ;;^UTILITY(U,$J,358.3,1293,2)
 ;;=^295629
 ;;^UTILITY(U,$J,358.3,1294,0)
 ;;=V73.81^^15^108^31
 ;;^UTILITY(U,$J,358.3,1294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1294,1,3,0)
 ;;=3^SCREEN-HPV
 ;;^UTILITY(U,$J,358.3,1294,1,4,0)
 ;;=4^V73.81
 ;;^UTILITY(U,$J,358.3,1294,2)
 ;;=^335323
 ;;^UTILITY(U,$J,358.3,1295,0)
 ;;=V73.88^^15^108^10
 ;;^UTILITY(U,$J,358.3,1295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1295,1,3,0)
 ;;=3^SCREEN-CHLAMYDIA
 ;;^UTILITY(U,$J,358.3,1295,1,4,0)
 ;;=4^V73.88
 ;;^UTILITY(U,$J,358.3,1295,2)
 ;;=^295832
 ;;^UTILITY(U,$J,358.3,1296,0)
 ;;=V73.89^^15^108^63
 ;;^UTILITY(U,$J,358.3,1296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1296,1,3,0)
 ;;=3^SCREEN-VIRAL DISEASE 
 ;;^UTILITY(U,$J,358.3,1296,1,4,0)
 ;;=4^V73.89
 ;;^UTILITY(U,$J,358.3,1296,2)
 ;;=^295833
 ;;^UTILITY(U,$J,358.3,1297,0)
 ;;=V74.0^^15^108^11
 ;;^UTILITY(U,$J,358.3,1297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1297,1,3,0)
 ;;=3^SCREEN-CHOLERA
 ;;^UTILITY(U,$J,358.3,1297,1,4,0)
 ;;=4^V74.0
 ;;^UTILITY(U,$J,358.3,1297,2)
 ;;=^295633
 ;;^UTILITY(U,$J,358.3,1298,0)
 ;;=V74.1^^15^108^51
 ;;^UTILITY(U,$J,358.3,1298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1298,1,3,0)
 ;;=3^SCREEN-PULMONARY TB
 ;;^UTILITY(U,$J,358.3,1298,1,4,0)
 ;;=4^V74.1
 ;;^UTILITY(U,$J,358.3,1298,2)
 ;;=^108715
 ;;^UTILITY(U,$J,358.3,1299,0)
 ;;=V74.2^^15^108^37
 ;;^UTILITY(U,$J,358.3,1299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1299,1,3,0)
 ;;=3^SCREEN-LEPROSY
 ;;^UTILITY(U,$J,358.3,1299,1,4,0)
 ;;=4^V74.2
 ;;^UTILITY(U,$J,358.3,1299,2)
 ;;=^295634
 ;;^UTILITY(U,$J,358.3,1300,0)
 ;;=V74.3^^15^108^19
 ;;^UTILITY(U,$J,358.3,1300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1300,1,3,0)
 ;;=3^SCREEN-DIPHTHERIA
 ;;^UTILITY(U,$J,358.3,1300,1,4,0)
 ;;=4^V74.3
 ;;^UTILITY(U,$J,358.3,1300,2)
 ;;=^295635
 ;;^UTILITY(U,$J,358.3,1301,0)
 ;;=V74.4^^15^108^6
 ;;^UTILITY(U,$J,358.3,1301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1301,1,3,0)
 ;;=3^SCREEN-BACT CONJUNCTIVIT
 ;;^UTILITY(U,$J,358.3,1301,1,4,0)
 ;;=4^V74.4
 ;;^UTILITY(U,$J,358.3,1301,2)
 ;;=^295636
 ;;^UTILITY(U,$J,358.3,1302,0)
 ;;=V74.5^^15^108^62
 ;;^UTILITY(U,$J,358.3,1302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1302,1,3,0)
 ;;=3^SCREEN-VENERAL DIS
 ;;^UTILITY(U,$J,358.3,1302,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,1302,2)
 ;;=^295637
 ;;^UTILITY(U,$J,358.3,1303,0)
 ;;=V74.6^^15^108^64
 ;;^UTILITY(U,$J,358.3,1303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1303,1,3,0)
 ;;=3^SCREEN-YAWS
 ;;^UTILITY(U,$J,358.3,1303,1,4,0)
 ;;=4^V74.6
 ;;^UTILITY(U,$J,358.3,1303,2)
 ;;=^295638
 ;;^UTILITY(U,$J,358.3,1304,0)
 ;;=V74.8^^15^108^7
 ;;^UTILITY(U,$J,358.3,1304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1304,1,3,0)
 ;;=3^SCREEN-BACTERIAL DIS NEC
 ;;^UTILITY(U,$J,358.3,1304,1,4,0)
 ;;=4^V74.8
 ;;^UTILITY(U,$J,358.3,1304,2)
 ;;=^295639
 ;;^UTILITY(U,$J,358.3,1305,0)
 ;;=V75.0^^15^108^55
